| Analysis | Metabolite Name | Measured Value | Units | Treament | Exposure |
|---|---|---|---|---|---|
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 827907776 | Area under curve | Water | Air |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 861921216 | Area under curve | Antibiotics | Ozone |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 911578944 | Area under curve | Water | Air |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 922749824 | Area under curve | Antibiotics | Ozone |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 1023805952 | Area under curve | Water | Air |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 1037284864 | Area under curve | Antibiotics | Ozone |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 1064878272 | Area under curve | Water | Ozone |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 1070152576 | Area under curve | Water | Air |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 1085056128 | Area under curve | Water | Air |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 1093773824 | Area under curve | Antibiotics | Ozone |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 1158155904 | Area under curve | Antibiotics | Ozone |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 1187399552 | Area under curve | Antibiotics | Ozone |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 1302017920 | Area under curve | Water | Ozone |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 1302161664 | Area under curve | Antibiotics | Ozone |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 1320271488 | Area under curve | Water | Ozone |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 1432319744 | Area under curve | Water | Ozone |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 1443478912 | Area under curve | Water | Ozone |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 1449367680 | Area under curve | Water | Ozone |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 1478636288 | Area under curve | Antibiotics | Air |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 1592332416 | Area under curve | Antibiotics | Air |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 1613237632 | Area under curve | Water | Air |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 1619528832 | Area under curve | Water | Air |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 1859666816 | Area under curve | Antibiotics | Ozone |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 2014882944 | Area under curve | Antibiotics | Ozone |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 2054613120 | Area under curve | Water | Ozone |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 2169362432 | Area under curve | Water | Ozone |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 2366640896 | Area under curve | Water | Air |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 2419134720 | Area under curve | Antibiotics | Air |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 2555727616 | Area under curve | Antibiotics | Air |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 2580858112 | Area under curve | Antibiotics | Air |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 2689708800 | Area under curve | Antibiotics | Air |
| Reversed phase LC-MS Negative | docosahexaenoate (DHA; 22:6n3) | 2963723520 | Area under curve | Antibiotics | Air |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|